SERES THERAPEUTICS INC's ticker is MCRB and the CUSIP is 81750R102. A total of 125 filers reported holding SERES THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.54 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,646,491 | -50.3% | 691,803 | 0.0% | 0.73% | -51.0% |
| Q2 2023 | $3,313,736 | -2.1% | 691,803 | +15.9% | 1.50% | +7.5% |
| Q1 2023 | $3,383,873 | +8.8% | 596,803 | 0.0% | 1.39% | +214.4% |
| Q4 2022 | $3,109,000 | -3.7% | 596,803 | -4.8% | 0.44% | -37.7% |
| Q3 2022 | $3,228,000 | +21.3% | 626,803 | +30.1% | 0.71% | +134.7% |
| Q2 2022 | $2,662,000 | -22.4% | 481,803 | 0.0% | 0.30% | -61.9% |
| Q1 2022 | $3,430,000 | -14.5% | 481,803 | 0.0% | 0.80% | -26.0% |
| Q4 2021 | $4,013,000 | +19.7% | 481,803 | 0.0% | 1.08% | +71.1% |
| Q3 2021 | $3,353,000 | – | 481,803 | – | 0.63% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Flagship Pioneering Inc. | 21,571,764 | $610,696,000 | 16.87% |
| RA Capital Management | 4,750,000 | $134,473,000 | 2.46% |
| ARK Investment Management | 12,293,033 | $348,016,000 | 2.06% |
| Opaleye Management Inc. | 335,312 | $9,493,000 | 1.86% |
| Sio Capital Management, LLC | 316,800 | $8,969,000 | 1.78% |
| Ikarian Capital, LLC | 762,400 | $21,585,000 | 1.56% |
| Nikko Asset Management Americas, Inc. | 5,531,670 | $152,176,000 | 1.35% |
| EAM Global Investors LLC | 121,629 | $3,443,000 | 1.26% |
| EAM Investors, LLC | 133,591 | $3,782,000 | 0.90% |
| GILDER GAGNON HOWE & CO LLC | 3,185,420 | $90,179,000 | 0.56% |